Clinical Scorecard: Evaluation of Modern Quality Metrics in Vestibular Surgery: Are They Effective in Assessing Postoperative Complications Associated with Vestibular Schwannomas?

At a Glance

Key Highlights

• Current quality metrics focus mainly on 30-day postoperative outcomes and may not fully capture VS-specific complications.
• Facial nerve function preservation and hearing outcomes remain critical challenges in VS surgery.
• Longer observation periods beyond 30 days may be necessary to adequately assess postoperative complications and quality indicators.

Guideline-Based Recommendations

Diagnosis

• Use Gardner Robertson scale to stratify hearing function pre- and postoperatively.
• Grade facial nerve function using House & Brackman classification.
• Stratify tumor growth by Hannover tumor extension grading scale and measure largest tumor diameter including intracanalicular portion.

Management

• Discuss treatment options (wait and see, radiotherapy, surgery) based on tumor size, patient preference, and comorbidities.
• Perform retrosigmoid microsurgical resection with intraoperative neuromonitoring of cranial nerves V, VII, VIII, and somatosensory evoked potentials.
• Aim for complete resection when possible while prioritizing facial nerve preservation.
• Follow subtotal resection with serial imaging or radiation therapy as indicated.

Monitoring & Follow-up

• Routine clinical evaluation at 6 weeks postoperatively and MRI follow-up at 3 months.
• Annual MRI for complete resection cases; semiannual MRI for residual tumor surveillance.
• Monitor for adverse events including reoperation, readmission, CSF leak, surgical site infection, and new persistent facial nerve dysfunction.

Risks

• New persistent facial nerve dysfunction defined as House & Brackman grade III or higher lasting >3 months.
• Postoperative complications include CSF leak, surgical site infection, hemorrhage, hydrocephalus, and tumor recurrence.
• Comorbidities assessed by Charlson comorbidity index influence risk profiles.

Patient & Prescribing Data

Patients undergoing microsurgical vestibular schwannoma resection without neurofibromatosis type II or bilateral tumors

Treatment decisions individualized based on tumor size, patient wishes, and comorbidities; intraoperative neuromonitoring used to optimize nerve preservation; follow-up tailored to extent of resection and tumor recurrence risk

Clinical Best Practices

• Employ standardized grading scales for hearing and facial nerve function to assess outcomes.
• Use intraoperative neuromonitoring techniques including EMG, MEP, DNS, and AEP to identify and preserve cranial nerves.
• Implement longer postoperative observation periods beyond 30 days to capture relevant complications.
• Incorporate risk stratification using comorbidity indices to inform perioperative management.
• Provide multidisciplinary consultation including neurosurgery and radiation oncology for small tumors.

References

• Gardner Robertson scale for hearing function
• House & Brackman facial nerve grading system
• Hannover tumor extension grading scale
• Charlson comorbidity index
• Intraoperative neuromonitoring in vestibular schwannoma surgery